SPHERA FUNDS MANAGEMENT LTD. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 94 filers reported holding REATA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$699,084
-87.9%
7,689
-87.0%
0.12%
-79.3%
Q3 2020$5,761,000
-55.0%
59,139
-27.9%
0.57%
-53.0%
Q2 2020$12,801,000
+152.0%
82,049
+29.7%
1.20%
+53.4%
Q3 2019$5,080,000
-52.3%
63,269
-43.9%
0.78%
-46.1%
Q2 2019$10,640,000
+52.2%
112,769
+37.9%
1.46%
+128.2%
Q1 2019$6,989,000
-43.7%
81,769
-63.0%
0.64%
-54.4%
Q4 2018$12,413,000
+63.7%
221,269
+138.6%
1.40%
+60.8%
Q3 2018$7,581,000
+59.4%
92,719
-31.8%
0.87%
+32.6%
Q2 2018$4,757,000
+3.1%
136,044
-39.5%
0.66%
-6.4%
Q1 2018$4,615,000
-27.6%
225,0000.0%0.70%
-6.3%
Q4 2017$6,372,000
-0.1%
225,000
+9.8%
0.75%
-17.8%
Q3 2017$6,376,000205,0000.91%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders